av/dr-reddys--big.svg

NYSE:RDY

Dr. Reddy's Laboratories Limited

  • Stock

USD

Last Close

5,811.60

21/05 10:00

Market Cap

973.05B

Beta: 0.24

Volume Today

491.29K

Avg: 213.67K

PE Ratio

19.34

PFCF: 35.19

Dividend Yield

0.02%

Payout:12.73%

Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
net income
21.51B
-
22.18B
3.10%
20.01B
9.77%
12.04B
39.84%
9.81B
18.55%
18.80B
91.67%
19.50B
3.74%
19.15B
1.79%
23.57B
23.08%
60.48B
156.64%
depreciation and amortization
7.11B
-
8.10B
13.99%
10.25B
26.54%
11.28B
10.02%
11.71B
3.84%
12.19B
4.10%
12.47B
2.31%
12.80B
2.60%
11.82B
7.60%
12.50B
5.73%
deferred income tax
5.09B
-
5.98B
17.47%
7.13B
19.10%
2.61B
63.32%
4.54B
73.49%
3.65B
19.56%
-1.47B
140.19%
9.18B
725.85%
8.73B
4.85%
15.30B
75.26%
stock based compensation
436M
-
498M
14.22%
471M
5.42%
398M
15.50%
454M
14.07%
389M
14.32%
521M
33.93%
584M
12.09%
592M
1.37%
397M
32.94%
change in working capital
-10.39B
-
-15.04B
44.77%
-188M
98.75%
-5.35B
2,745.74%
-8.96B
67.55%
-5.77B
35.62%
-7.54B
30.58%
-8.29B
9.98%
-13.91B
67.88%
-7.86B
43.55%
accounts receivables
1.80B
-
-12.45B
792.60%
2.08B
116.72%
-17.01B
917.49%
-5.75B
66.19%
inventory
-3.97B
-
-5.45B
37.17%
-2.52B
53.70%
-6.33B
150.79%
-3.23B
48.89%
-8.50B
162.79%
-1.49B
82.50%
-9.88B
564.49%
-5.33B
46.08%
-2.65B
50.19%
accounts payables
398M
-
1.58B
295.98%
2.86B
81.54%
4.41B
54.21%
23M
99.48%
other working capital
-6.42B
-
-9.59B
49.47%
2.33B
124.33%
975M
58.23%
-5.73B
687.79%
530M
109.25%
4.82B
809.62%
-3.35B
169.47%
4.01B
219.86%
528M
86.85%
other non cash items
-4.30B
-
3.31B
177.09%
3.57B
7.91%
535M
85.03%
488M
8.79%
-547M
212.09%
6.35B
1,261.24%
2.29B
64.00%
-2.69B
217.71%
-21.96B
715.60%
net cash provided by operating activities
19.46B
-
25.03B
28.62%
41.25B
64.77%
21.51B
47.84%
18.03B
16.19%
28.70B
59.21%
29.84B
3.96%
35.70B
19.64%
28.11B
21.27%
58.87B
109.45%
investments in property plant and equipment
-10.63B
-
-15.33B
44.23%
-14.88B
2.95%
-40.98B
175.52%
-11.04B
73.06%
-7.49B
32.17%
-6.12B
18.37%
-12.56B
105.41%
-19.05B
51.65%
-18.86B
0.97%
acquisitions net
546M
-
-276M
150.55%
-7.94B
2,775.36%
-103M
98.70%
1.75B
1,800.97%
536M
69.41%
214M
60.07%
-15.51B
7,349.53%
-326M
97.90%
23.37B
7,268.10%
purchases of investments
-44.81B
-
-53.47B
19.31%
-68.25B
27.65%
-49.65B
27.25%
-68.43B
37.82%
-78.57B
14.82%
-111.92B
42.44%
-75.42B
32.61%
-88.97B
17.97%
-136.17B
53.05%
sales maturities of investments
37.72B
-
45.18B
19.76%
69.27B
53.33%
71.59B
3.36%
64.04B
10.56%
76.29B
19.13%
111.70B
46.42%
79.53B
28.80%
77.77B
2.21%
112.81B
45.05%
other investing activites
551M
-
989M
79.49%
1.37B
38.22%
672M
50.84%
-1.20B
278.72%
1.51B
225.73%
1.19B
21.06%
1.30B
9.48%
4.19B
221.00%
-22.51B
637.34%
net cash used for investing activites
-16.62B
-
-22.90B
37.81%
-20.42B
10.83%
-18.47B
9.56%
-14.88B
19.43%
-7.73B
48.08%
-4.92B
36.29%
-22.66B
360.29%
-26.39B
16.45%
-41.37B
56.79%
debt repayment
-5.29B
-
-3.72B
29.69%
-11.71B
215.02%
-5.22B
55.41%
-15.18B
-
-23.40B
54.13%
-4.50B
80.78%
-785M
82.54%
-1.01B
29.30%
common stock issued
2M
-
206M
10,200%
1M
99.51%
1M
0%
1M
0%
15.18B
1,518,100%
4M
99.97%
269M
6,625%
334M
24.16%
368M
10.18%
common stock repurchased
8.08B
-
2.98B
63.13%
-15.69B
-
-535M
-
-474M
11.40%
-1.19B
151.69%
451M
137.80%
647M
43.46%
dividends paid
-2.98B
-
-3.59B
20.17%
-4.11B
14.47%
-3.39B
17.44%
-3.99B
17.76%
-4.00B
0.25%
-3.92B
2.15%
-4.15B
5.90%
-4.15B
0.02%
-4.98B
20.09%
other financing activites
-25M
-
1M
104%
-1.19B
119,100%
20.61B
1,832.02%
-449M
102.18%
-16.79B
3,639.20%
2.63B
115.65%
9.27B
252.87%
1.72B
81.40%
-21.88B
1,369.26%
net cash used provided by financing activities
-217M
-
-4.12B
1,797.70%
-17.00B
312.85%
-3.69B
78.28%
-4.44B
20.26%
-21.33B
380.32%
-25.16B
17.97%
-298M
98.82%
-2.42B
712.75%
-26.86B
1,009.04%
effect of forex changes on cash
771M
-
-1.07B
238.52%
-4.30B
302.25%
-492M
88.55%
57M
111.59%
35M
38.60%
-25M
171.43%
113M
552%
733M
548.67%
286M
60.98%
net change in cash
3.40B
-
-3.06B
189.99%
-473M
84.53%
-1.14B
141.44%
-1.24B
8.32%
-314M
74.62%
-266M
15.29%
12.86B
4,933.83%
32M
99.75%
-9.07B
28,453.13%
cash at beginning of period
5.05B
-
8.45B
67.21%
5.39B
36.17%
4.92B
8.77%
3.78B
23.21%
2.54B
32.73%
2.23B
12.35%
1.96B
11.94%
14.82B
655.35%
14.85B
0.22%
cash at end of period
8.45B
-
5.39B
36.17%
4.92B
8.77%
3.78B
23.21%
2.54B
32.73%
2.23B
12.35%
1.96B
11.94%
14.82B
655.35%
14.85B
0.22%
5.78B
61.09%
operating cash flow
19.46B
-
25.03B
28.62%
41.25B
64.77%
21.51B
47.84%
18.03B
16.19%
28.70B
59.21%
29.84B
3.96%
35.70B
19.64%
28.11B
21.27%
58.87B
109.45%
capital expenditure
-10.63B
-
-15.33B
44.23%
-14.88B
2.95%
-40.98B
175.52%
-11.04B
73.06%
-7.49B
32.17%
-6.12B
18.37%
-12.56B
105.41%
-19.05B
51.65%
-18.86B
0.97%
free cash flow
8.84B
-
9.71B
9.85%
26.37B
171.71%
-19.47B
173.83%
6.99B
135.88%
21.21B
203.65%
23.73B
11.85%
23.14B
2.46%
9.06B
60.85%
40.01B
341.65%

All numbers in USD (except ratios and percentages)